4.7 Article

Twelve-year weight change, waist circumference change and incident obesity: The Australian diabetes, obesity and lifestyle study

期刊

OBESITY
卷 22, 期 6, 页码 1538-1545

出版社

WILEY
DOI: 10.1002/oby.20704

关键词

-

资金

  1. National Health and Medical Research Council (NHMRC) [233200, 1007544]
  2. Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd.
  3. Alphapharm Pty Ltd.
  4. Amgen Australia
  5. AstraZeneca
  6. Bristol-Myers Squibb
  7. City Health Centre-Diabetes Service-Canberra
  8. Department of Health and Community Services, Northern Territory
  9. Department of Health and Human Services, Tasmania
  10. Department of Health, New South Wales
  11. Department of Health, Western Australia
  12. Department of Health, South Australia
  13. Department of Health, Western Australia
  14. Department of Health, South Australia
  15. Department of Human Services, Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson
  16. GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia
  17. Marian & FH Flack Trust, Menzies Research Institute
  18. Merck Sharp Dohme
  19. Novartis Pharmaceuticals
  20. Novo Nordisk Pharmaceuticals
  21. Pfizer Pty Ltd.
  22. Pratt Foundation, Queensland Health, Roche Diagnostics Australia
  23. Royal Prince Alfred Hospital, Sydney
  24. Sanofi Aventis
  25. sanofi-synthelabo
  26. Victorian Government's OIS Program

向作者/读者索取更多资源

Objective This study aimed to describe the changes in weight and waist circumference (WC), examine the incidence of obesity as defined by body mass index (BMI) and WC, and describe the changes in the prevalence of obesity over 12 years. Methods In 1999/2000, 11,247 adults aged 25 years were recruited from 42 randomly selected areas across Australia. In total, 44.6% of eligible participants completed follow-up in 2011/12. Height, weight, and WC were measured at both surveys. Results People who were 25-34 years of age at baseline gained an average of 6.7 kg weight and 6.6 cm WC, whereas those aged 75 years lost an average of 4.5 kg and gained an average of 0.8 cm. Women had a greater increase in WC than men, but did not differ in terms of weight gain. The 12-year incidence of obesity was 15.0% when defined by BMI and 31.8% when defined by WC. According to BMI and WC combined, the percentage of the cohort that was normal weight decreased from 33 to 21% and the percentage that was obese increased from 32 to 49% between baseline and 2012. Conclusions In addition to BMI, assessment of WC should be incorporated more frequently when assessing population trends of obesity and the burden of disease associated with excess adiposity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据